newsfilter
← Latest News
PR Newswire·

Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital

RED BANK, N.J., Aug. 31, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company has secured a term loan faci